IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caligan Partners LP

Q4 2022 Holdings

Filed 2023-02-15 | 11 holdings | $120.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-05-15) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Liquidia Corp(LQDA)ACOM NEW53635D202$58.9M9,243,62749.0%
Anika Therapeutics Inc(ANIK)COM035255108$17.5M591,67514.6%
Evolus Inc(EOLS)COM30052C107$13.1M1,740,70010.9%
Adma Biologics Inc(ADMA)COM000899104$10.4M2,676,0938.6%
Standard Biotools Inc(LAB)COM34385P108$10.0M8,576,7998.4%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$4.8M183,0644.0%
Societal Cdmo IncCOM75629F109$2.4M1,603,2142.0%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$1.5M435,2981.3%
Alimera Sciences IncCOM NEW016259202$1.3M478,7771.1%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$159.3K1,0000.1%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$121.7K4,3330.1%